Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen receptor

T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen receptor

US Patent 11091532 · Granted Aug 17, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antigen-binding domain2025
Antigen-binding domain2025
Engineered cytolytic immunecell2025
Engineered cytolytic immunecell2025
Engineered cytolytic immunecell2025
Engineered cytolytic immunecell2025
Cytolytic immune cell comprising BCMA- and CD19-specific chimeric antigen recept2025
Cytolytic immune cell comprising BCMA- and CD19-specific chimeric antigen recept2025
Cytolytic immune cell comprising BCMA- and CD19-specific chimeric antigen recept2025
Cytolytic immune cell comprising BCMA- and CD19-specific chimeric antigen recept2025
Cell lexpressing two chimeric antigen receptors (CARs) at the cell surface2025
Cell lexpressing two chimeric antigen receptors (CARs) at the cell surface2025